Aclarion, Inc.
ACON

NASDAQ > Medical - Healthcare Information Services
DCF:$2.28  |   P/E: -
$0.00(1.68%)
Change
Rating:
Price: $0.1249 USD
Market Cap: $1.33M

...Loading ACON Peers...





Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

    4 Employees

    CEO : Mr. Brent Ness

    Address : 951 Mariners Island Boulevard, San Mateo,CA, US, - 94404,

Key ExcutivesDesignation
Mr. Brent NessChief Executive Officer, President & Director
Mr. John LorbieckiChief Financial Officer
Mr. Ryan BondChief Strategy Officer
Dr. Jeffrey John Thramann M.D.Executive Chairman